Concourse Financial Group Securities, Inc. Novo Nordisk A S Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 46,584 shares of NVO stock, worth $4.07 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

46,584

Previous 47,082 1.06%

Holding current value

$4.07 Million

Previous $6.72 Million 17.47%

% of portfolio

0.34%

Previous 0.43%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$119.07 - $145.42 $59,296 - $72,419	-498 Reduced 1.06%	46,584 $5.55 Million
Q2 2024 Jul 23, 2024	SELL	$122.71 - $146.91 $23,683 - $28,353	-193 Reduced 0.41%	47,082 $6.72 Million
Q1 2024 Apr 30, 2024	BUY	$102.11 - $135.92 $1.02 Million - $1.36 Million	10,023 Added 26.91%	47,275 $6.07 Million
Q4 2023 Feb 07, 2024	BUY	$87.78 - $105.45 $252,630 - $303,485	2,878 Added 8.37%	37,252 $3.85 Million
Q3 2023 Oct 25, 2023	BUY	$90.94 - $199.54 $1.58 Million - $3.46 Million	17,334 Added 101.73%	34,374 $3.13 Million
Q2 2023 Aug 10, 2023	BUY	$155.98 - $172.65 $1.39 Million - $1.53 Million	8,881 Added 108.85%	17,040 $2.76 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $26,600 - $31,987	-201 Reduced 2.4%	8,159 $1.3 Million
Q4 2022 Jan 30, 2023	BUY	$102.55 - $135.33 $6,358 - $8,390	62 Added 0.75%	8,360 $0
Q3 2022 Nov 15, 2022	SELL	$95.28 - $116.93 $12,100 - $14,850	-127 Reduced 1.51%	8,298 $827,000
Q2 2022 Aug 09, 2022	BUY	$103.24 - $121.81 $783,591 - $924,537	7,590 Added 908.98%	8,425 $939,000
Q1 2022 May 09, 2022	SELL	$93.1 - $112.54 $69,359 - $83,842	-745 Reduced 47.15%	835 $94,000
Q4 2021 Feb 07, 2022	BUY	$95.88 - $117.08 $15,532 - $18,966	162 Added 11.42%	1,580 $177,000
Q3 2021 Nov 09, 2021	BUY	$84.42 - $106.62 $79,270 - $100,116	939 Added 196.03%	1,418 $136,000
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $879 - $1,101	-13 Reduced 2.64%	479 $40,000
Q1 2021 May 13, 2021	BUY	$67.06 - $75.82 $1,408 - $1,592	21 Added 4.46%	492 $34,000
Q4 2020 Feb 02, 2021	SELL	$63.89 - $73.8 $4,280 - $4,944	-67 Reduced 12.45%	471 $33,000
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $18,215 - $20,082	-286 Reduced 34.71%	538 $37,000
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $1,463 - $1,698	-25 Reduced 2.94%	824 $54,000
Q1 2020 May 13, 2020	SELL	$49.46 - $64.78 $52,922 - $69,314	-1,070 Reduced 55.76%	849 $52,000
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $21,639 - $25,284	434 Added 29.23%	1,919 $111,000
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $285 - $320	-6 Reduced 0.4%	1,485 $77,000
Q2 2019 Aug 13, 2019	BUY	$46.79 - $52.47 $10,668 - $11,963	228 Added 18.05%	1,491 $76,000
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $14,835 - $16,841	320 Added 33.93%	1,263 $66,000
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $5,358 - $6,095	129 Added 15.85%	943 $43,000
Q3 2018 Nov 13, 2018	BUY	$46.76 - $51.24 $38,062 - $41,709	814 New	814 $38,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account

Concourse Financial Group Securities, Inc. Novo Nordisk A S Transaction History